Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 3 4Phase 1/2 3Phase 1 2Phase 4 1Phase 2/3 1

Status

Completed 6Recruiting 1

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Interventional 7

Sponsor

Cancer Type

Lymphoid 4Plasma cell 2Other hematologic neoplasm 1CNS 1

Conditions

Recurrence 2Multiple Myeloma 2Lymphoma, B-Cell 2Burkitt Lymphoma 2Neoplasms, Plasma Cell 1Neoplasms 1Meningeal Carcinomatosis 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma 1Leukemia, Myeloid, Acute 1Hodgkin Disease 1

Interventions

Cisplatin 1519Carboplatin 1420Cyclophosphamide 1360Gemcitabine 1235Bevacizumab 1226Paclitaxel 1211Radiotherapy 1176Docetaxel 1080pembrolizumab 1028Oxaliplatin 936Capecitabine 901Fluorouracil 833Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 666Etoposide 660Irinotecan 622Leucovorin 575Pemetrexed 510Drug Therapy 493Cetuximab 483Trastuzumab 469Cytarabine 466Magnetic Resonance Spectroscopy 458Filgrastim 446Prednisone 433Lenalidomide 409Specimen Handling 408Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 2 × Interventional × Transplantation, Autologous × Clear all
NCT05852717 2026-05-06

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

Hoosier Cancer Research Network

Phase 2 Recruiting
32 enrolled
Lymphoid

Neoplasms, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT02244125 2025-11-24

PCD

Institut Curie

Phase 2 Completed
100 enrolled
Plasma cell

Multiple Myeloma, Recurrence, Neoplasms, Plasma Cell

NCT00801216 2024-12-10

SCNSL1

IRCCS San Raffaele

Phase 2 Completed
40 enrolled 11 charts
CNSLymphoid

Lymphoma, B-Cell, Meningeal Carcinomatosis

NCT01141712 2023-01-04

Autologous Transplant in HIV Patients (BMT CTN 0803)

Medical College of Wisconsin

Phase 2 Completed
43 enrolled 21 charts
Lymphoid

Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Lymphoma, Follicular, Lymphoma, B-Cell

NCT01516593 2022-08-04

CARMEN

IRCCS San Raffaele

Phase 2 Completed
19 enrolled
Lymphoid

Burkitt Lymphoma

NCT01660633 2020-04-21

Safety & Efficacy Study High Dose Evomela Injection for MA Conditioning in MM Patients With Autologous Transplantation

Acrotech Biopharma Inc.

Phase 2 Completed
61 enrolled
Plasma cell

Multiple Myeloma

NCT01716793 2012-11-01

Risk-adapted Therapy for Adult Acute Myeloid Leukemia.

Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias

Phase 2 Completed
354 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡